Literature DB >> 30461466

Outcomes, Satisfaction, and Costs of a Rheumatology Telemedicine Program: A Longitudinal Evaluation.

Patrick R Wood, Liron Caplan.   

Abstract

OBJECTIVES: Rural veterans with inflammatory arthritis (IA) lack medical access because of geographic barriers. Telemedicine (TM) holds great promise in relieving these disparities. We have prospectively measured patient-centered data surrounding a TM care program at a federal health system and compared these with usual care (UC).
METHODS: Veterans with previously established IA were enrolled in TM follow-up. Data collected longitudinally before and after entering the program included Routine Assessment of Patient Index Data 3 (RAPID-3), out-of-pocket visit costs and distances traveled, and patient satisfaction instruments. Demographics were recorded. Similar data were collected on a convenience sample of concurrent IA patients receiving UC.
RESULTS: Eighty-five patients were observed, including 25 receiving TM care and 60 receiving UC. No differences in demographics, satisfaction scores, or RAPID-3 were noted at baseline between groups. Univariate linear regression of cross-sectional baseline data suggests satisfaction instrument scores were predicted by RAPID-3 (β = -0.64/10 points, p = 0.01), as well as distance (β = -0.19/100 miles, p = 0.02) and cost (β = -0.37/$100, p = 0.05). A multivariate model indicates both distance (β = -0.17/100 miles, p = 0.02) and RAPID-3 (β = -0.47/10 points, p < 0.03) were predictors for visit satisfaction. In longitudinal follow-up via TM, satisfaction (Δ = 0.03, p = 0.94) and RAPID-3 (Δ = 0.27, p = 0.89) remained similar to baseline among TM patients, whereas distance traveled (Δ = -384.8 miles/visit, p < 0.01) and visit costs (Δ = -$113.8/visit, p < 0.01) were reduced.
CONCLUSIONS: Patient-reported outcomes for care delivered via TM were similar to UC, with significant cost and distance savings. Patient-centered factors such as distance to care should be considered in design care delivery models, as they appear to drive patient satisfaction in conjunction with disease control.

Entities:  

Mesh:

Year:  2019        PMID: 30461466     DOI: 10.1097/RHU.0000000000000778

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  14 in total

1.  Factors Associated With Use of Telemedicine for Follow-up of Rheumatoid Arthritis.

Authors:  Elizabeth D Ferucci; Peter Holck; Gretchen M Day; Tammy L Choromanski; Sarah L Freeman
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-10       Impact factor: 4.794

2.  E-consults: an effective way to decrease clinic wait times in rheumatology.

Authors:  Veena Patel; Diana Stewart; Molly J Horstman
Journal:  BMC Rheumatol       Date:  2020-10-15

3.  Management of Rheumatic Diseases During the COVID-19 Pandemic: A National Veterans Affairs Survey of Rheumatologists.

Authors:  Jasvinder A Singh; John S Richards; Elizabeth Chang; Amy Joseph; Bernard Ng
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-07       Impact factor: 4.794

Review 4.  Challenges, collaboration, and innovation in rheumatology education during the COVID-19 pandemic: leveraging new ways to teach.

Authors:  Anisha B Dua; Adam Kilian; Rebecca Grainger; Sarah A Fantus; Zachary S Wallace; Frank Buttgereit; Beth L Jonas
Journal:  Clin Rheumatol       Date:  2020-10-16       Impact factor: 2.980

5.  Rheumatology Patient Satisfaction With Telemedicine During the COVID-19 Pandemic in the United States.

Authors:  Mahta Mortezavi; Sravani Lokineni; Megha Garg; Ya Li Chen; Allison Ramsey
Journal:  J Patient Exp       Date:  2021-04-23

6.  Patient and Caregiver Experience with Outpatient Palliative Care Telemedicine Visits.

Authors:  Brook Calton; William Patrick Shibley; Eve Cohen; Steven Z Pantilat; Michael W Rabow; David L O'Riordan; Kara E Bischoff
Journal:  Palliat Med Rep       Date:  2020-12-28

7.  Ability and willingness to utilize telemedicine among rheumatology patients-a cross-sectional survey.

Authors:  Steve S Kong; Lilian A Otalora Rojas; Amnie Ashour; Mathew Robinson; Tyler Hosterman; Neha Bhanusali
Journal:  Clin Rheumatol       Date:  2021-07-04       Impact factor: 2.980

8.  Tele-Rheumatology During the COVID-19 Pandemic.

Authors:  Jesús Tornero-Molina; Fernando Sánchez-Alonso; Manuel Fernández-Prada; María-Luisa Bris-Ochaita; Alberto Sifuentes-Giraldo; Javier Vidal-Fuentes
Journal:  Reumatol Clin (Engl Ed)       Date:  2020-10-29

9.  Evaluation of a Non-Face-to-Face Multidisciplinary Health Care Model in a Population with Rheumatoid Arthritis Vulnerable to COVID-19 in a Health Emergency Situation.

Authors:  Pedro Santos-Moreno; Gabriel-Santiago Rodríguez-Vargas; Rosangela Casanova; Jaime-Andrés Rubio-Rubio; Josefina Chávez-Chávez; Diana Patricia Rivera-Triana; Ruth Alexandra Castiblanco-Montañez; Sandra Milena Hernández-Zambrano; Laura Villareal; Adriana Rojas-Villarraga
Journal:  Healthcare (Basel)       Date:  2021-12-17

10.  National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.

Authors:  Joel M Gelfand; April W Armstrong; Stacie Bell; George L Anesi; Andrew Blauvelt; Cassandra Calabrese; Erica D Dommasch; Steve R Feldman; Dafna Gladman; Leon Kircik; Mark Lebwohl; Vincent Lo Re; George Martin; Joseph F Merola; Jose U Scher; Sergio Schwartzman; James R Treat; Abby S Van Voorhees; Christoph T Ellebrecht; Justine Fenner; Anthony Ocon; Maha N Syed; Erica J Weinstein; Jessica Smith; George Gondo; Sue Heydon; Samantha Koons; Christopher T Ritchlin
Journal:  J Am Acad Dermatol       Date:  2020-09-04       Impact factor: 15.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.